
PETMED EXPRESS INC
PETSNASDAQTrading Snapshot
- Day Range
- $1.97 β $2.01
- 52-Week Range
- $1.57 β $4.10
- Volume
- $2.79B
- Avg Volume
- $3.13B
- Shares Outstanding
- 21.4M
- Next Earnings
- Sep 16, 2026
Fundamentals Snapshot
- Annual Revenue
- $179M
- Last Q Revenue
- $43M
- P/E Ratio
- β
- P/S Ratio
- 0.2x
- EPS (TTM)
- $-2.75
- Dividend Yield
- 0.06%
Why Investors Own PETS
- βHigh-growth profile β revenue up +12.1% YoY with expanding US Equity exposure.
- βHealthy economics β 74% gross margin and 24% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About PETMED EXPRESS INC
PetMed Express, Inc., through its various subsidiaries, operates as a prominent pet pharmacy across the United States. The company provides a comprehensive range of both prescribed and over-the-counter animal medications, health-related items, and other essential supplies for canines, felines, and equines. Their non-prescription offerings include products for flea and tick prevention, joint and bone care, vitamins, treats, nutritional supplements, hygiene essentials, and general pet supplies. For prescription needs, they supply heartworm and flea/tick preventatives, alongside medications for conditions such as arthritis, dermatitis, thyroid imbalances, diabetes, pain relief, and cardiovascular issues, often providing generic alternatives. Beyond pharmaceuticals, the company also retails pet food, bedding, crates, stairs, and various other accessories. PetMed Express engages with its clientele through multiple distribution channels: its official website, a dedicated mobile application, a telephone contact center, direct mail campaigns (like brochures and postcards), and television advertisements, frequently promoting its 1-800-PetMeds and PetMeds brands. The company was established in 1996 and is headquartered in Delray Beach, Florida.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
PETMED EXPRESS INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift PETS price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
PETMED EXPRESS INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.